Extended use combination comprising estrogens and progestins

Details for Australian Patent Application No. 2004292778 (hide)

Owner Schering Aktiengesellschaft

Inventors Endrikat, Jan; Schurmann, Rolf; Dusterberg, Bernd

Agent Davies Collison Cave

Pub. Number AU-A-2004292778

PCT Pub. Number WO2005/051400

Priority 03090405.6 26.11.03 EP

Filing date 20 November 2004

Wipo publication date 9 June 2005

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/569 (2006.01)

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/051400 Priority application(s): WO2005/051400

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292802-Trousers with an adjustable waist

2004292775-Tubular proteinuria as an indicator for elevated cardiovascular risk